new meningitis b jab - effective against 80 per cent of strains found in europe - could be approved for use by the spring -lrb- pictured posed by model -rrb- .
it is the most common form of bacterial meningitis and the toughest challenge for scientists because there are so many strains to target .
there is currently no vaccine to protect against meningococcal b in this country .